The Asia-Pacific initial public offering market has recorded its strongest first-half performance since 2021, with 110 listings across the region's major exchanges raising a combined 82 billion US dollars in the period from January through June 2026, according to data compiled by Refinitiv. The recovery, from a deeply suppressed 2023 and 2024 base, has been driven by a combination of improved market sentiment, better-than-expected earnings from regional corporates, and the resolution of several large transactions that had been delayed by market conditions.
Hong Kong Leads the Revival
Hong Kong recaptured its position as the region's leading IPO venue by proceeds raised, with 38 listings on the Main Board and Growth Enterprise Market raising a combined 34 billion US dollars in the period. The Hong Kong Stock Exchange's listing reforms, implemented in phases since 2022 and including the introduction of specialised technology company and biotech listing regimes under Chapters 18A, 18B and 19C, have attracted a diverse pipeline of issuers across technology, biomedical science and advanced manufacturing sectors.
The largest Hong Kong listing of the period was the 12.4-billion-dollar IPO of a Greater Bay Area semiconductor manufacturer, which was 8.6 times oversubscribed in the institutional allocation round and saw its shares advance 34 percent on the first day of trading. The listing reinforced Hong Kong's position as the preferred international capital market for mainland Chinese technology companies seeking access to international investors.
Hong Kong's Main Board hosted 38 IPOs in H1 2026, raising US$34 billion and reclaiming its position as the region's leading venue by proceeds.
India's Domestic Powerhouse
India's NSE and BSE exchanges delivered the highest number of listings across the region, with 41 IPOs raising a combined 28 billion US dollars. India's retail investor base, which has expanded to over 120 million active demat accounts, and the strong domestic institutional flows from insurance companies and pension funds, provided a reliable and deep demand base for new issuers. Consumer technology, fintech, and renewable energy companies dominated the Indian pipeline.
SEBI's streamlined IPO approval process, which was reduced to an average of 32 days from application to listing following reforms introduced in 2025, has significantly improved the time-to-market for Indian companies and reduced the risk of market window closings that previously caused valuable issuers to withdraw or reschedule.
China and Sectoral Trends
Chinese domestic exchanges, A-share markets in Shanghai and Shenzhen, and the Beijing Stock Exchange continued to channel a large volume of domestic IPO activity but with lower international investor participation than Hong Kong. China's CSRC approval-based system recorded 29 new listings raising 14 billion US dollars in the period, with new energy vehicles, power electronics and industrial automation companies comprising the largest sectoral cohort.
India delivered 41 IPOs raising $28 billion, powered by 120 million retail investors and strong domestic institutional demand from pension and insurance funds.
Biotech and Green Energy Drive New Listings
Across the region, biotechnology and green energy companies represented the fastest-growing segments of the IPO market by deal count. Eleven biotech companies listed across the region's exchanges in the first half of 2026, including four Hong Kong Chapter 18A pre-revenue biotech listings that collectively raised 4.6 billion dollars. Green energy IPOs, including solar developers, battery manufacturers and offshore wind operators, raised 8.9 billion dollars across the region.
Proceeds from IPOs in traditional sectors such as real estate, retail and conventional manufacturing declined sharply, reflecting the structural shift in investor appetite toward growth-oriented, technology-intensive and sustainability-linked businesses. Average price-to-earnings multiples at listing for tech and biotech companies significantly exceeded those of their traditional sector counterparts.
Second-Half Outlook
Investment banks project that the second half pipeline will be at least equivalent in volume to the first half, supported by a queue of high-quality issuers that have received regulatory approval and are awaiting appropriate market windows. The primary risk factor is renewed market volatility, which can close IPO windows quickly and force issuers to defer listings by quarters rather than weeks. The rate-cutting cycle expected to begin in September should provide a supportive backdrop if implemented as signalled.